SARS-CoV-2 ORF3a antibody (C-Term)
Quick Overview for SARS-CoV-2 ORF3a antibody (C-Term) (ABIN7272993)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- anti-ORF3a (SARS-CoV-2)
-
Sequence
- MNSVTSSIVI TSGDGTTSPI SEHDYQIGGY TEKWESGVKD CVVLHSYFTS DYYQLYSTQL STDTGVEHVT FFIYNKIVDE PEEHVQIHTI DGSSGVVNPV MEPIYDEPTT TTSVPL
-
Specificity
- In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Cross-Reactivity (Details)
- Reacts with SARS-CoV-2 protein
-
Purification
- Epitope affinity purified
-
Immunogen
- Affinity purified fusion recombinant protein using the C-terminal of ORF3a (residues 160 to stop) and produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:2,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- The antibody solution should be gently mixed before use.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- SARS-CoV-2 ORF3a
-
Alternative Name
- ORF3a (SARS-CoV-2)
-
Target Type
- Viral Protein
-
Background
-
ORF3a encodes a viral accessory and uncharacterised protein with possible role in the viral life cycle. Six functional domains have been identified and have linked to infectivity, virulence, ion channel formation and virus release.
ORF3a SARS Coronavirus-2 antibody.
Target
-